Log in
Enquire now
Anbition Srl

Anbition Srl

Anbition Srl is developing new molecules and technologies for treating or diagnosing angiogenesis-related diseases

OverviewStructured DataIssuesContributors

All edits by  Даниил Талан 

Edits on 22 Feb, 2022
Даниил Талан profile picture
Даниил Талан
edited on 22 Feb, 2022
Edits made to:
Infobox (+4 properties)
Article (+263 characters)
Table (+3 rows) (+6 cells) (+65 characters)
Topic thumbnail

Anbition Srl

Anbition Srl is developing new molecules and technologies for treating or diagnosing angiogenesis-related diseases

Article

ANBITION activities are focused on developing new molecules and technologies useful for treating or diagnosing angiogenesis-related diseases, including eye neo-vascular disease such as macular oedema, wet age-related macular degeneration and diabetic retinopathy.

Table

Name
Role
LinkedIn

Davide Rosiello

CEO

Menotti Ruvo

co-founder

Sandro De Falco

co-founder

Infobox
Email address
davide.rosiello@bioviiix.cominfo@bioviiix.com
Fax number
+39 081 2397208
Phone number
+39 081 2395462

Find more companies like Anbition Srl

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.